UT Southwestern Medical Center researchers have discovered that brain tumours are capable of burning acetate for fuel, providing a new potential target for halting tumour growth. The opensource study is published in the journal Cell.
The medical community are currently investigating what fuels cancer cell growth. For more than 75 years, researchers have known that cancer cells use glucose as the major fuel, but efforts to halt cancer growth by controlling glucose levels in the brain haven’t worked.
The team identified that glucose wasn’t the only fuel being burned. Acetate can be used to generate fuel and metabolites that can then be used to make other things that the cell needs to survive and multiply.
The current study employed specially engineered mouse models so that the tumours grown in the brain were very similar to human tumours, especially with respect to the molecular and metabolic characteristics. They then infused both 13C-acetate and 13C-glucose into the mice and were able to show that the tumours burn acetate as fuel.
This is the first demonstration of acetate being used by the cell in this way. The striking finding was that all cancers the group studied had the same ability to burn acetate. All the tumours studied increased expression of ACSS2, the acetate metabolizing enzyme, and the gliomas appear to be dependent on acetate for growth.
The researchers then validated their findings in two patients with glioblastomas and two patients with brain metastases (breast and lung cancer) who were undergoing surgical resection of their tumours. The analysis showed that the human tumours robustly burned acetate. ACSS2 may thus be a therapeutic target for these very aggressive tumours that have limited therapies available.
The team summise that the insights provided by the current study position acetate metabolism as a potentially exploitable vulnerability in cancer metabolism.
Source: UT Southwestern Medical Center
Michelle Petersen is the founder of Healthinnovations, having worked in the health and science industry for over 21 years, which includes tenure within the NHS and Oxford University. Healthinnovations is a publication that has reported on, influenced, and researched current and future innovations in health for the past decade.
Michelle has been picked up as an expert writer for Informa publisher’s Clinical Trials community, as well as being listed as a blog source by the world’s leading medical journals, including the acclaimed Nature-Springer journal series.
Healthinnovations is currently indexed by the trusted Altmetric and PlumX metrics systems, respectively, as a blog source for published research globally. Healthinnovations is also featured in the world-renowned BioPortfolio, BioPortfolio.com, the life science, pharmaceutical and healthcare portal.
Most recently the Texas A&M University covered The Top 10 Healthinnovations series on their site with distinguished Professor Stephen Maren calling the inclusion of himself and his team on the list a reflection of “the hard work and dedication of my students and trainees”.
Michelle Petersen’s copy was used in the highly successful marketing campaign for the mega-hit film ‘Jumanji: The Next Level, starring Jack Black, Karen Gilian, Kevin Hart and Dwayne ‘The Rock’ Johnson. Michelle Petersen’s copywriting was part of the film’s coverage by the Republic TV network. Republic TV is the most-watched English language TV channel in India since its inception in 2017.
An avid campaigner in the fight against child sex abuse and trafficking, Michelle is a passionate humanist striving for a better quality of life for all humans by helping to provide traction for new technologies and techniques within healthcare.